Guide for Authors

  • European Psychiatry

    http://ees.elsevier.com/eurpsy

    Guide for Authors

    Please click here for a PDF of the Guide for Authors.

    European Psychiatry is the official journal of the European Psychiatric Association (EPA). European Psychiatry publishes 8 issues per year with articles on original research on pre-clinical and clinical scientific fields investigating the aetiology, pathophysiology and treatment of major psychiatric disorders. European Psychiatry accepts publications originating from any part of the world based only on their scientific merit. European Psychiatry does not have publication fees.

    Manuscripts are accepted for consideration by European Psychiatry with the understanding that they represent original material, have not been published previously, are not being considered for publication elsewhere, and have been approved by each author. Manuscripts on clinical trials will only be considered if reporting on trials registered in a public trials registry. Please consult our Editorial Policy on clinical trials.

    All articles are published in English. The quality of the English language is of paramount importance as it influences how the manuscript is received by Editors, reviewers and readers. For authors who are not English speakers and may not be experienced in scientific writing in English we strongly recommend the use of appropriate language services. The authors may consider any option available to them including the language services provided by Elsevier. More information can be found at http://webshop.elsevier.com/languageservices/ Please note that the use of language services is at the authors cost and does not guarantee that the manuscript will be reviewed or accepted.

    ARTICLE TYPES

    • European Psychiatry does not accept book reviews, case reports, short communications or letters (unless part of an invited commentary).
    • Types of accepted articles and their specifications are shown in the table below
    • Word count for the main manuscript includes only the main body of text (i.e., not tables, figures, abstracts or references)
    • All pages should be numbered
    • Manuscripts should be double-spaced
    • All abbreviations (other than those for units of measure) should be spelled out the first time they are used anywhere in the manuscript. Idiosyncratic abbreviations should not be used.
    Article Type Abstract Main Manuscript Figures Tables References
    Original Research Word limit: 250

    Structured:
    Background Methods, Results, Conclusions

    Word Limit: 3500

    Structured:
    Introduction, Methods, Results, Discussion

    Up to 5 Up to 5 Up to 75
    Reviews, Meta-analyses Word Limit: 250

    Structured:
    Background, Methods, Results, Conclusions

    Word Limit: 5000

    Structured:
    Introduction, Methods, Results, Discussion

    No limit No limit Up to 200
    Guidance papers
    (invitation only)
    Word limit: 250 Word Limit: 5000

    Structured:
    Introduction, Methods,Results, Discussion

    No limit No limit Up to 200
    Letters to the Editor
    (Invitation only)
    None Word Limit: 500 None None Up to 10

    ETHICAL CONSIDERATIONS

    Ethical Approval and Informed Consent
    Any study that reports results based on direct contact with human subjects (regardless of the procedures used) must include a statement that ethical approval, and written informed consent was obtained after the procedure(s) had been fully explained. Studies on vulnerable adult populations (e.g., prisoners, cognitively impaired individuals) should also describe the process of assessing capacity and safeguards that were in place to protect study participants. Studies that use archival information on human subjects (e.g., electronic medical records, research databases, national registries) should include information about the ethical framework of the study and specify whether anonymized or deidentified data were used. In the case of children, it should include information about whether the child's assent was obtained. Submissions that do not contain the relevant information on ethical approval and consent will not be reviewed.

    Care of Animals
    Studies reporting experiments on animals, should include a statement that institutional and national guidelines for the care and use of laboratory animals were followed.

    ARTICLE PRESENTATION

    Each article should include the following components

    1. Cover letter

    2. Title page

    3. Abstract

    4. Keywords

    5. Introduction

    6. Methods

    7. Results

    8. Discussion

    9. Funding and other Support

    10. Acknowledgement (Optional)

    11. Conflict of Interest

    12. References

    13. Tables

    14. Figure legends

    15. Figures

    16. Supplemental material (online only)

    1. Cover letter: This must include a statement that (a) the manuscript contains original work that has not been published or is under consideration elsewhere; (b) all authors have seen and approved the submitted version of the article; (c) explains the novelty and importance of the data. For papers that include previously published data, please consult the Editorial Policy.

    2. Title page: The title page should show the title of the paper first. The title should be brief and informative. Whenever possible the title should encapsulate the key message of the article. Then, the full names (including middle initials) of the authors should be given followed by their affiliations. For affiliations please state department, institution, town and country. If authors are affiliated with multiple institutions, each affiliation should be numbered. This number should appear as superscript next to the last name of the affiliated author. Please consult the Editorial Policy on the eligibility criteria for authorship.Finally, the name, postal address, email and telephone number (with country and area code) of the corresponding author should be stated. There can be only one corresponding author.

    3. Abstract: The abstract should be up to 250 words long and should be structured into background, methods (data sources, subjects, design, measurements, data analysis), results and conclusions. If abbreviations are used these should be spelled in full first. For clinical trials, registration information (name, number, and URL) should be listed at the end of the abstract.

    4. Keywords: Three to six keywords should be chosen carefully, as they are used for indexing purposes. Whenever possible avoid duplicating words already in the title.

    5. Introduction: It is recommended that the Introduction not exceed 1000 words. European Psychiatry is not a specialist journal. Therefore, in your introduction ensure that you provide sufficient information for an interested general reader to appreciate the context and importance of your work and the hypotheses tested. If abbreviations are used in the Introduction these should be spelled in full first.

    6. Methods: Please consult the journal's policy on data reporting before you proceed. In general, this section should provide sufficient information to allow the independent reproduction of the methods used. Subheadings are strongly encouraged to improve readability. Subheadings should not be numbered.For well-established techniques, provide a brief description only, supported by appropriate references. For new techniques, provide key information in the main text and additional details, if necessary, as supplemental online material. For manuscripts that include multiple different techniques consider providing a brief description of each technique in the main text and details as supplemental online material. You should provide the name and location of the manufacturer for named equipment and instruments. Drug should be identified by their pharmaceutical names. Trade names should be used only when directly relevant.Standard deviations, rather than standard errors of the mean, are required. All significant and important non-significant results must include the test value, degree(s) of freedom and probability. For manuscripts that report on randomized clinical trials, you are required to provide all CONSORT material. The CONSORT statement, checklist and flow diagram can be found at http://www.consort-statement.org.

    7. Results: Please consult the journal's policy on data reporting before you proceed. In general, the results section should present the data as text, tables and figures. The same information should not be presented in more than one format. For example, information presented as tables should not be described in the text. Subheadings are strongly encouraged to improve readability. Subheadings should not be numbered.

    8. Discussion: It is recommended that you begin the Discussion with a paragraph or less summarizing the key findings of the article. The Discussion should not repeat the results. The Discussion should focus on providing an objective interpretation of the results and on explaining how they inform the field. The Discussion should include appropriate details on the methodological or other limitations of the study. The last two paragraphs of the Discussion should provide a concluding summary and should discuss specific directions for future research.

    9. Funding and other support: This should include information about funding sources or other financial support (including in kind support) you might have received during the study or in connection to the writing up the manuscript. Details of the policy regarding funding can be found at the journal's Editorial Policy.

    10. Acknowledgements (Optional): If applicable, this could include names of contributors that do not meet authorship criteria, please see the journal's Editorial Policy.

    11. Conflict of Interest: Any competing financial interests in relation to the work described should be described here and will be published as part of the manuscript. Details of the policy regarding conflicts of interest reporting can be found at the journal's Editorial Policy.

    12. References: References are in Vancouver format (International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Fifth Edition. N Engl J Med 1997;336:309-16). In the text, references should appear as numbers between brackets based on the order of citation. At the end of the manuscript, they should be listed in numerical order corresponding to the order of citation in the text. Authors are responsible for the accuracy of their references. All references should be cited in the text by number between brackets based on the order they appear in the text. They should be listed at the end of the main text using the same numbering. All references cited in the text should be listed and all listed references should appear next to the corresponding text. References in tables and figures should also be numbered. List all authors. The names of the journals should be abbreviated according to those used in the latest edition of Index Medicus. The volume, issue and first and last pages should be included. Abstracts should be marked as such. Papers that have been submitted or accepted but are not available online should not be cited. Papers in preparation should not be cited.

    Examples

    Journal article, published in print:Schneider C, Corrigall R, Hayes D, Kyriakopoulos M, Frangou S. Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia. Eur Psychiatry. 2014;29(1):1-10.
    Journal article, published online only (either in press or in electronic only journal):
    Schneider C, Corrigall R, Hayes D, Kyriakopoulos M, Frangou S. Systematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophrenia. Eur Psychiatry doi: 10.1016/j.eurpsy.2013.08.001.
    Book
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM5), 5th ed. Washington, DC: American Psychiatric Press. 2013.
    Book Chapter
    Smith AB. In: Jones AB, editor. Principles of Science, 2nd ed. New York: Elsevier. 2014; 111-171.

    13. Tables: Tables should be cited in the text and numbered consecutively (i.e., 1, 2, 3) in the order they appear. Tables should include brief descriptive title. Abbreviations should be spelled in full in footnotes. Table footnotes should use superscript lowercase letters and not symbols.
    Tables should be included on the same file as the main manuscript.

    14-15. Figures and Figure Legends: Figures should be cited in the text and numbered consecutively (i.e., 1, 2, 3) in the order they appear. The preferred file format for figures and graphics is EPS, TIFF, or PDF. Please upload high quality versions of each figure separately (i.e., two figures should be uploaded separately as Figure 1 and Figure 2). Parts/panels in composite figures should be labeled with capital letters (A, B, C). Each figure should be consistent in color, size, and font, and be designed proportionally so that each item within it is to scale (particularly numbers, letters, and symbols) so it can later be sized as needed without loss of legibility or quality. Figure titles and legends should be included as text in the manuscript file and not in the figure file itself. Complete instructions for electronic artwork preparation and submission can be found at http://www.elsevier.com/artwork.

    You can enrich your online articles by providing 3D neuroimaging data in NIfTI format. This will be visualized for readers using the interactive viewer embedded within your article, and will enable them to browse through available neuroimaging datasets; zoom, rotate and pan the 3D brain reconstruction; cut through the volume; change opacity and color mapping; switch between 3D and 2D projected views; and download the data. The viewer supports both single (.nii) and dual (.hdr and .img) NIfTI file formats. Recommended size of a single uncompressed dataset is 100 MB. Multiple datasets can be submitted. Each dataset should be zipped and uploaded separately. Please provide a short informative description for each dataset by filling in the 'Description' field when uploading a dataset. If an article is accepted, all uploaded datasets will be available for download from the online article on ScienceDirect.

    If you have concerns about your data being downloadable, please provide a video instead. For more information, see: http://www.elsevier.com/3DNeuroimaging

    16. Supplemental material (optional): Supplemental data to be posted online should provide essential information in support of the scientific integrity and excellence of the printed manuscript. The material should follow the same format as for the main article and will be available to reviewers. Examples of essential supplemental data include: 1) detailed tables, 2) detailed description of methodological techniques, particularly for manuscripts that use multiple different approaches, or for articles reporting new techniques, 3) the CONSORT table and figure for clinical trials, 4) appendices such as questionnaires, tests, checklists, etc., 5) figures and graphic illustrating data or techniques. Supplemental data should be uploaded in a separate file from the main manuscript. All information in the supplemental material should be mentioned in the main manuscript. Supplemental Tables or supplemental figures should be indicated as STable or SFigure and they should be numbered sequentially in the order of their appearance in the supplemental material. References should be included as a separate list from the references in the main manuscript but should have the same formating. Supplemental material is not typeset or proofed and so should be carefully prepared. All supplemental information (including text, tables, and figures) should be uploaded in a single Word document (Doc, Docx) file.

    Special Style Considerations: Gene symbols should be differentiated by species. Symbols for human genes should be all uppercase. Symbols for other species should be lowercase using only an initial capital. Protein products, regardless of species, are not italicized and use all uppercase letters. Approved human gene symbols are available from HUGO Gene Nomenclature Committee (HGNC) at http://www.genenames.org/.Approved mouse symbols are available from the Jackson Laboratory at http://www.informatics.jax.org/mgihome/nomen.

    Please note there is also a help menu, accessible from all screens during the submission process

    SUBMISSION

    Please note there is a help menu, accessible from all screens during the submission process.

    Please submit your articles electronically via the Elsevier Editorial System (EES). To access EES, visit http://ees.elsevier.com/eurpsy.

    First time user: Register by entering your first and last names, and e-mail address. Soon after you will receive a confirmation of your username and password, which will give you access at all times, via author-login.

    Registered user: Please use your existing account with Elsevier.Submission Process: Please follow the instructions provided in the journal's website. During submission you will be asked to indicate your preference regarding the handling editor. Information about each of the Editors can be found at http://www.europsy-journal.com/edboard.

    During submission you are required to provide the names, affiliations and email addresses of the 5 reviewers. This should exclude reviewers who work at the same institution as any author, or those who have any other obvious conflict of interest. The journal editors cannot be named as reviewers. The editors will consider the suggested reviewers but the actual reviewer selection remains fully at their discretion.

    Please submit each document in the formal specified in the journal's website. The system will then build a single PDF of the submission from the uploaded files.

    Submission: All correspondence takes place by e-mail and will be addressed to the corresponding author only. Immediately following submission, the corresponding author will receive an e-mail of receipt by the Editorial Office. If there is no such e-mail confirmation, the corresponding author should investigate the problem further. The manuscript status is available to the corresponding author at all times by logging into the journal's website. Please ensure you notify the handling editor if the corresponding author's email address changes post-submission.In case of technical difficulties, please contact authorsupport@elsevier.com.

    REVIEW PROCESS

    Editorial rejection: All manuscripts receive an initial review by the journal editors following which they may be returned without being peer-reviewed. Editorial rejection is communicated to authors usually within 10 days of submission and allows authors to resubmit their papers elsewhere with minimal delay. Manuscripts may be rejected because they focus on issues of regional interest that may have limited appeal to a general readership, or because their findings represent a relatively small advance on the present state of knowledge, or because their subject matter is more appropriate for other specialist journals.

    Peer review: All submissions that pass editorial review will be subject to peer review (with exception of letters that form part of an invited commentary).The reviewers are selected by the editors and may include those suggested by the authors. The identity of individual reviewers remains confidential to all parties except the Editorial Office. Reviewers are expected to treat manuscripts under review with the strictest confidentiality.

    As a general rule, a) papers will be evaluated by two independent reviewers; additional reviewers may be enlisted on occasions for specialist advice including review for statistical adequacy, b) the reviewers' comments will be communicated to the authors within 30-45 days of submission.

    Revisions: The corresponding author will be notified by e-mail about the request to make revisions to their manuscript. The authors should submit a 'clean' revised version. All changes should be detailed in the accompanying Response to Reviewers file. Authors have 90 days to respond. Thereafter, the manuscript will be automatically considered withdrawn if there has been no communication with the editorial office or submission of revisions.

    ACCEPTANCE

    The corresponding author will receive e-mail notification of acceptance typically within 10 days of the final manuscript revision. Manuscripts are accepted with the understanding that the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with journal style.

    COPYRIGHT TRANSFER / OPEN ACCESS

    The journal requires transfer of copyright to Elsevier, the publisher, upon acceptance, unless you have opted for open access. If you are using open access, please click here.

    If you have not opted for open access, a copyright transfer form is available here. This must be signed by all authors upon acceptance of the paper. Accepted manuscripts will not be scheduled for publication until a completed form has been received. The corresponding author is responsible for overseeing the completion of the copyright transfer forms.

    PUBLICATION PROCESS

    The editorial office does not participate in the publication process.

    Proofs: The corresponding author will receive proofs by e-mail from Elsevier, the publisher, generally within 30 days of acceptance. Proofs must be corrected and returned within 48 hours of receipt. Corrected proofs become available online within 30 days of their receipt. Authors should carefully review and proofread the entire article because once a corrected proof becomes available online, additional corrections cannot be made without an erratum. The corresponding author is responsible for overseeing the timely return and accuracy of the corrected proofs. Any queries during this process should be directed to europsy@elsevier.com.

    Early view: Corrected proofs become available online within 30 days of their receipt. They are immediately citable, with an assigned digital object identifier (DOI) number. Any queries during this process should be directed to europsy@elsevier.com.

    Printed Article: Generally, articles appear in the print copy of the journal within 6 months of acceptance. Any queries during this process should be directed to europsy@elsevier.com.

undefined